Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.74B
-
Number of holders
-
1473
-
Total 13F shares, excl. options
-
1.01B
-
Shares change
-
+6.88M
-
Total reported value, excl. options
-
$49.6B
-
Value change
-
+$345M
-
Put/Call ratio
-
1.33
-
Number of buys
-
558
-
Number of sells
-
-686
-
Price
-
$49.08
Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q2 2015
1,575 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q2 2015.
ABBOTT LABORATORIES - Common Stock (ABT) has 1,473 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.01B shares
of 1.74B outstanding shares and own 58.09% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (90.8M shares), STATE STREET CORP (61.4M shares), BlackRock Institutional Trust Company, N.A. (39M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (33M shares), Bank of New York Mellon Corp (29.4M shares), JPMORGAN CHASE & CO (25.7M shares), JENNISON ASSOCIATES LLC (21.1M shares), BlackRock Fund Advisors (19.9M shares), GOLDMAN SACHS GROUP INC (18.2M shares), and PRIMECAP MANAGEMENT CO/CA/ (17.7M shares).
This table shows the top 1473 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.